Literature DB >> 4783699

Theory of the measurement of arterial compliance in humans.

J G Defares, M E Wise.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4783699     DOI: 10.1007/bf02558809

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


× No keyword cloud information.
  7 in total

1.  THEORETICAL SYNTHESIS OF THE CARDIOVASCULAR SYSTEM. STUDY I: THE CONTROLLED SYSTEM.

Authors:  J G DEFARES; J J OSBORN; H H HARA
Journal:  Acta Physiol Pharmacol Neerl       Date:  1963

2.  A study of the mechanism of pressure wave distortion by arterial walls using an electrical analog.

Authors:  H R WARNER
Journal:  Circ Res       Date:  1957-01       Impact factor: 17.367

3.  Venous PCO 2 and cardiac output obtained from rebreathing curves: by extrapolation or by a plateau method?

Authors:  M E Wise; J G Defares
Journal:  Clin Sci       Date:  1972-08       Impact factor: 6.124

4.  A method for the determination of systemic arterial complicance in man.

Authors:  J G Defares; H J van der Waal
Journal:  Acta Physiol Pharmacol Neerl       Date:  1969-08

5.  Comparison of CO2 rebreathing and acetylene methods for cardiac output.

Authors:  K Klausen
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

6.  On the theory of the cardiovascular system.

Authors:  J G Defares; J J Osborn; H H Hara
Journal:  Bull Math Biophys       Date:  1965

7.  On the form of the physiological CO2 dissociation curve, the physiological O2 dissociation curve, and the diffusion curves of O2 and CO2 along the capillary path.

Authors:  J G DEFARES; B F VISSER
Journal:  Ann N Y Acad Sci       Date:  1962-03-02       Impact factor: 5.691

  7 in total
  1 in total

1.  High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.

Authors:  J H Henriksen; S Møller; S Schifter; J Abrahamsen; U Becker
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.